Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lefebvre

Showing results (121-130 of 229) with videos related to

Pageof 23
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1992
S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptorsM J Millan, J M Rivet, H Canton, et al.
Oncology Nursing Forum|July 5, 2022
Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-AnalysisHaya Waseem, Pamela K Ginex, Kapeena Sivakumaran, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2019
Increase in ST-11 serogroup W <i>Neisseria meningitidis</i> invasive meningococcal disease in Canada, 2016-2018R S Tsang, L Hoang, G J Tyrrell, et al.
Journal of Clinical Microbiology|August 21, 2015
Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test SpecimensS W Peterson, I Martin, W Demczuk, et al.
Oncology Nursing Forum|October 16, 2020
ONS Guidelines™ for Opioid-Induced and Non-Opioid-Related Cancer ConstipationBarbara Rogers, Pamela K Ginex, Allison Anbari, et al.
Journal of Clinical Microbiology|April 17, 2015
Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeaeS W Peterson, I Martin, W Demczuk, et al.
Emerging Infectious Diseases|December 23, 2015
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, CanadaI Martin, P Sawatzky, G Liu, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 2020
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samplesS W Peterson, I Martin, W Demczuk, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 25, 2019
Multidrug-resistant and extensively drug-resistant <i>Neisseria gonorrhoeae</i> in Canada, 2012-2016I Martin, P Sawatzky, V Allen, et al.
Journal of Oncology Practice|November 22, 2016
2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric OncologyMichael N Neuss, Terry R Gilmore, Kristin M Belderson, et al.
Pageof 23

Showing results (121-130 of 229) with videos related to

Sort By:
Pageof 23
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1992
S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptorsM J Millan, J M Rivet, H Canton, et al.
Oncology Nursing Forum|July 5, 2022
Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-AnalysisHaya Waseem, Pamela K Ginex, Kapeena Sivakumaran, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2019
Increase in ST-11 serogroup W <i>Neisseria meningitidis</i> invasive meningococcal disease in Canada, 2016-2018R S Tsang, L Hoang, G J Tyrrell, et al.
Journal of Clinical Microbiology|August 21, 2015
Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test SpecimensS W Peterson, I Martin, W Demczuk, et al.
Oncology Nursing Forum|October 16, 2020
ONS Guidelines™ for Opioid-Induced and Non-Opioid-Related Cancer ConstipationBarbara Rogers, Pamela K Ginex, Allison Anbari, et al.
Journal of Clinical Microbiology|April 17, 2015
Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeaeS W Peterson, I Martin, W Demczuk, et al.
Emerging Infectious Diseases|December 23, 2015
Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, CanadaI Martin, P Sawatzky, G Liu, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 2020
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samplesS W Peterson, I Martin, W Demczuk, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 25, 2019
Multidrug-resistant and extensively drug-resistant <i>Neisseria gonorrhoeae</i> in Canada, 2012-2016I Martin, P Sawatzky, V Allen, et al.
Journal of Oncology Practice|November 22, 2016
2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric OncologyMichael N Neuss, Terry R Gilmore, Kristin M Belderson, et al.
Pageof 23